NetworkNewsBreaks – DarioHealth Corp. (NASDAQ: D
Post# of 188
(Total Views: 224)
Posted On: 09/02/2020 3:08:13 PM
NetworkNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) CEO Discusses Transformation to B2B2C Digital Therapeutics
DarioHealth (NASDAQ: DRIO), a global digital-therapeutics company serving its users with dynamic mobile-health solutions, has recently achieved a series of successes and anticipates even more in the coming weeks. Among drivers of DRIO’s path toward leading cutting-edge solutions is the global pandemic, which has unveiled dynamics of the company’s business model that provide distinction in an era in need of next-generation health care. A recent article discussing this includes commentary from DarioHealth’s CEO Erez Raphael, who stated, “The COVID-19 pandemic has accelerated our ongoing transformation to a business-to-business-to-consumer (‘B2B2C’) digital therapeutics leader. We advanced late-stage discussions with health plans and self-insured employers who we believe recognize how our industry-leading user engagement and satisfaction metrics lead to improved health for their member and employee populations. . . . We believe that we are poised to announce new and potentially transformational agreements in the next few weeks.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
DarioHealth (NASDAQ: DRIO), a global digital-therapeutics company serving its users with dynamic mobile-health solutions, has recently achieved a series of successes and anticipates even more in the coming weeks. Among drivers of DRIO’s path toward leading cutting-edge solutions is the global pandemic, which has unveiled dynamics of the company’s business model that provide distinction in an era in need of next-generation health care. A recent article discussing this includes commentary from DarioHealth’s CEO Erez Raphael, who stated, “The COVID-19 pandemic has accelerated our ongoing transformation to a business-to-business-to-consumer (‘B2B2C’) digital therapeutics leader. We advanced late-stage discussions with health plans and self-insured employers who we believe recognize how our industry-leading user engagement and satisfaction metrics lead to improved health for their member and employee populations. . . . We believe that we are poised to announce new and potentially transformational agreements in the next few weeks.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)DarioHealth Corp. (DRIO) Stock Research Links
Scroll down for more posts ▼